70 related articles for article (PubMed ID: 3044834)
1. Circulating tumour cell liquid biopsy in selecting therapy for recurrent cutaneous melanoma with locoregional pelvic metastases: a pilot study.
Guadagni S; Fiorentini G; Papasotiriou I; Apostolou P; Masedu F; Sarti D; Farina AR; Mackay AR; Clementi M
BMC Res Notes; 2020 Mar; 13(1):176. PubMed ID: 32204733
[TBL] [Abstract][Full Text] [Related]
2. On the mound with melanoma: The Jim Umbricht story.
Hoenig LJ
Clin Dermatol; 2020; 38(1):123-125. PubMed ID: 32197742
[TBL] [Abstract][Full Text] [Related]
3. Leakage measurement during selective limb perfusion using a gamma probe.
Sandrock D; Horst F; Gatzemeier W; Ghorbani M; Rauschecker H; Munz DL; Emrich D
Eur J Nucl Med; 1996 May; 23(5):534-8. PubMed ID: 8698058
[TBL] [Abstract][Full Text] [Related]
4. [Improved intraoperative leak control in cytostatic drug isolation perfusion of tumors of the extremities].
Manner M; Sinn H; Bubeck H; Kettelhack C; Schlag P
Langenbecks Arch Chir; 1990; 375(4):208-13. PubMed ID: 2395387
[TBL] [Abstract][Full Text] [Related]
5. Cure and cosmesis in the management of primary malignant melanoma.
Neades GT; Hughes LE
Br J Cancer; 1990 Feb; 61(2):192-4. PubMed ID: 2178664
[No Abstract] [Full Text] [Related]
6. [Hyperthermic regional perfusion in malignant melanoma of an extremity].
Andersson AP; Drzewiecki KT
Ugeskr Laeger; 1992 Oct; 154(41):2815-9. PubMed ID: 1413222
[TBL] [Abstract][Full Text] [Related]
7. Repeat isolated limb perfusion with melphalan for recurrent melanoma of the limbs.
Klop WM; Vrouenraets BC; van Geel BN; Eggermont AM; Klaase JM; Nieweg OE; Kroon BB
J Am Coll Surg; 1996 Jun; 182(6):467-72. PubMed ID: 8646345
[TBL] [Abstract][Full Text] [Related]
8. Long-term outcome of hyperthermic isolated limb perfusion (HILP) in the treatment of locoregionally metastasised malignant melanoma of the extremities.
Boesch CE; Meyer T; Waschke L; Merkel S; Goehl J; Hohenberger W; Knorr C
Int J Hyperthermia; 2010 Feb; 26(1):16-20. PubMed ID: 20100048
[TBL] [Abstract][Full Text] [Related]
9. Repeat isolated limb perfusion with TNFalpha and melphalan for recurrent limb melanoma after failure of previous perfusion.
Noorda EM; Vrouenraets BC; Nieweg OE; van Geel AN; Eggermont AM; Kroon BB
Eur J Surg Oncol; 2006 Apr; 32(3):318-24. PubMed ID: 16412605
[TBL] [Abstract][Full Text] [Related]
10. Hyperthermic limb perfusion for malignant melanoma and soft tissue sarcoma.
Kettelhack C; Kraus T; Hupp T; Manner M; Schlag P
Eur J Surg Oncol; 1990 Aug; 16(4):370-5. PubMed ID: 2379595
[TBL] [Abstract][Full Text] [Related]
11. Conventional isolated hyperthermic antiblastic perfusion in the treatment of recurrent limb melanoma.
Decian F; Mondini G; Demarchi R; Muzio G; Sementa A; Bocchio MM; Spirito C; Simoni G; Civalleri D
Anticancer Res; 1996; 16(4A):2017-24. PubMed ID: 8712736
[TBL] [Abstract][Full Text] [Related]
12. Prophylactic hyperthermic limb perfusion in stage I melanoma.
Krige JE; King HS; Strover RM
Eur J Surg Oncol; 1988 Aug; 14(4):321-6. PubMed ID: 3044834
[TBL] [Abstract][Full Text] [Related]
13. [Hyperthermic-antiblastic isolation perfusion for advanced melanoma of the limbs. The technic, immediate results and a review of the literature].
Decian F; Balletto N; Camerini G; Depaoli M; D'Aniello R; Ameri A; Brisighella A; Bonalumi U; Bachi V; Civalleri D
Minerva Chir; 1990 Oct; 45(19):1227-37. PubMed ID: 2074944
[TBL] [Abstract][Full Text] [Related]
14.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
15.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
16.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
17.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
18.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
19.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
20.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Next] [New Search]